New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance
Published on 08/07/2025 at 18:06 | prnewswire.co.uk
en | boerse | 67955047 |
